BioNTech will invest $200 million and get access to Autolus’ manufacturing sites.
BioNTech and Autolus Announce Strategic Alliance to Bolster CAR-T Cell Pipeline
BioNTech will invest $200 million and get access to Autolus’ manufacturing sites.